Table 5.
Cost–benefit and sensitivity analysis
| Cost–benefit analysis | ||
|---|---|---|
| Calculation | Costs and benefits | Outcomea |
| 1. | Costs of SERVICE (Pharmacist labor) | |
| Admission | −€ 7476 | |
| Discharge | −€ 7256 | |
| 2. | Cost avoidance | |
| Admission | € 7911 | |
| Discharge | € 28,687 | |
| 3. (= 2–1) | Net cost–benefit | |
| During intervention period | € 21,868 | |
| Per patient (at admission) | € 103 | |
| 4. (= 2:1) | Cost–benefit ratio | 2.48 |
| Sensitivity analysis | ||
|---|---|---|
| Variable | Variation | Cost–benefit ratio |
| Time | + 50% minutes per intervention | 1.66 |
| − 50% minutes per intervention | 4.96 | |
| Salary | Highest point on hospital pharmacist scale | 2.22 |
| Lowest point on hospital pharmacist scale | 3.55 | |
| Pharmacy technician (7th year) | 7.73 | |
| ADE probability | − 50% | 1.24 |
| 50% | 3.73 | |
| ADE cost | Based on Bates et al. [28] | 16.52 |
ADE adverse drug event
aBased on 2014 Euro cost data